307 related articles for article (PubMed ID: 25006881)
1. The role of the gut microbiome in the development and progression of liver cirrhosis and hepatocellular carcinoma.
Roderburg C; Luedde T
Gut Microbes; 2014 Jul; 5(4):441-5. PubMed ID: 25006881
[TBL] [Abstract][Full Text] [Related]
2. Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats.
Zhang HL; Yu LX; Yang W; Tang L; Lin Y; Wu H; Zhai B; Tan YX; Shan L; Liu Q; Chen HY; Dai RY; Qiu BJ; He YQ; Wang C; Zheng LY; Li YQ; Wu FQ; Li Z; Yan HX; Wang HY
J Hepatol; 2012 Oct; 57(4):803-12. PubMed ID: 22727732
[TBL] [Abstract][Full Text] [Related]
3. Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma.
Zheng R; Wang G; Pang Z; Ran N; Gu Y; Guan X; Yuan Y; Zuo X; Pan H; Zheng J; Wang F
Cancer Med; 2020 Jun; 9(12):4232-4250. PubMed ID: 32281295
[TBL] [Abstract][Full Text] [Related]
4. Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis.
Jiang JW; Chen XH; Ren Z; Zheng SS
Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):19-27. PubMed ID: 30527903
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic Fatty Liver Disease and the Gut Microbiome.
Boursier J; Diehl AM
Clin Liver Dis; 2016 May; 20(2):263-75. PubMed ID: 27063268
[TBL] [Abstract][Full Text] [Related]
6. The Immunologic Role of Gut Microbiota in Patients with Chronic HBV Infection.
Yang R; Xu Y; Dai Z; Lin X; Wang H
J Immunol Res; 2018; 2018():2361963. PubMed ID: 30148173
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease.
Ponziani FR; Bhoori S; Castelli C; Putignani L; Rivoltini L; Del Chierico F; Sanguinetti M; Morelli D; Paroni Sterbini F; Petito V; Reddel S; Calvani R; Camisaschi C; Picca A; Tuccitto A; Gasbarrini A; Pompili M; Mazzaferro V
Hepatology; 2019 Jan; 69(1):107-120. PubMed ID: 29665135
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma.
Ren Z; Li A; Jiang J; Zhou L; Yu Z; Lu H; Xie H; Chen X; Shao L; Zhang R; Xu S; Zhang H; Cui G; Chen X; Sun R; Wen H; Lerut JP; Kan Q; Li L; Zheng S
Gut; 2019 Jun; 68(6):1014-1023. PubMed ID: 30045880
[TBL] [Abstract][Full Text] [Related]
9. [The role of gut microbiota in chronic liver diseases, and treatment possibilities].
Hagymási K; Bacsárdi A; Egresi A; Berta E; Tulassay Z; Lengyel G
Orv Hetil; 2018 Sep; 159(36):1465-1474. PubMed ID: 30175608
[TBL] [Abstract][Full Text] [Related]
10. The Gut Microbiome and Hepatocellular Carcinoma.
Akkız H
J Gastrointest Cancer; 2021 Dec; 52(4):1314-1319. PubMed ID: 34870783
[TBL] [Abstract][Full Text] [Related]
11. A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma.
Piñero F; Vazquez M; Baré P; Rohr C; Mendizabal M; Sciara M; Alonso C; Fay F; Silva M
Ann Hepatol; 2019; 18(3):480-487. PubMed ID: 31023615
[TBL] [Abstract][Full Text] [Related]
12. Human microbiome is a diagnostic biomarker in hepatocellular carcinoma.
Rao BC; Lou JM; Wang WJ; Li A; Cui GY; Yu ZJ; Ren ZG
Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):109-115. PubMed ID: 32037278
[TBL] [Abstract][Full Text] [Related]
13. Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 -/- mouse model.
Behary J; Raposo AE; Amorim NML; Zheng H; Gong L; McGovern E; Chen J; Liu K; Beretov J; Theocharous C; Jackson MT; Seet-Lee J; McCaughan GW; El-Omar EM; Zekry A
BMC Microbiol; 2021 Apr; 21(1):113. PubMed ID: 33858327
[TBL] [Abstract][Full Text] [Related]
14. Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.
Giannelli V; Di Gregorio V; Iebba V; Giusto M; Schippa S; Merli M; Thalheimer U
World J Gastroenterol; 2014 Dec; 20(45):16795-810. PubMed ID: 25492994
[TBL] [Abstract][Full Text] [Related]
15. Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis.
Grąt M; Wronka KM; Krasnodębski M; Masior Ł; Lewandowski Z; Kosińska I; Grąt K; Stypułkowski J; Rejowski S; Wasilewicz M; Gałęcka M; Szachta P; Krawczyk M
Transplant Proc; 2016 Jun; 48(5):1687-91. PubMed ID: 27496472
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota of Nonalcoholic Fatty Liver Disease.
Abdou RM; Zhu L; Baker RD; Baker SS
Dig Dis Sci; 2016 May; 61(5):1268-81. PubMed ID: 26898658
[TBL] [Abstract][Full Text] [Related]
17. Microbiota, NASH, HCC and the potential role of probiotics.
Brandi G; De Lorenzo S; Candela M; Pantaleo MA; Bellentani S; Tovoli F; Saccoccio G; Biasco G
Carcinogenesis; 2017 Mar; 38(3):231-240. PubMed ID: 28426878
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota and the liver.
Federico A; Dallio M; Caprio GG; Ormando VM; Loguercio C
Minerva Gastroenterol Dietol; 2017 Dec; 63(4):385-398. PubMed ID: 28927250
[TBL] [Abstract][Full Text] [Related]
19. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
[TBL] [Abstract][Full Text] [Related]
20. Gut Microbiota and Hepatocellular Carcinoma.
Tao X; Wang N; Qin W
Gastrointest Tumors; 2015 May; 2(1):33-40. PubMed ID: 26673641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
